/
CSBR
$5.02-$0.06 (-1.19%)live
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
1
institution
Market cap
$68.8M
14M shares
52-week range
$4.88 – $8.74
4% from low
Sector
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange
NASDAQ
CS
Change$-5.34
Champions Oncology, Inc.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment which is oncology services. Its research center operates in both regulatory and non-regulatory environments and consists of a comprehensive set of computational and experimental research platforms. The company's pharmacology, biomarker, and data platforms are designed to facilitate drug discovery and development at lower costs and increased speeds. Its revenue is majorly derived from research services.
www.championsoncology.com- Employees
- 214
- IPO / List date
- Oct 31, 1994
- HQ
- BALTIMORE, MD
Held by traders on TradeandTell
No one on the platform currently holds CSBR.
Super investors & insiders
Institutions holding (13F)
| Institution | Shares | Reported |
|---|---|---|
| Renaissance Technologiesas of 2026-03-31 | 145,539 | $836.8K |
Insider activity (SEC Form 4)
Stock splits
| Execution date | Ratio |
|---|---|
| 2015-08-12 | 1-for-12reverse |
Recent trades on TradeandTell
No one on the platform has traded CSBR yet.
